We are live on
!
Find out more
UA
URS Advisory Portfolio holdings
AUM
$180M
This Fund
S&P 500
This Quarter
Est. Return
+16.89%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$42.9M
(+31%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
12.59%
Top 10 Holdings %
Top 10 Hldgs %
68.35%
Holding
61
New
10
Increased
35
Reduced
11
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$3.88M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.54M |
| 3 |
State Street SPDR S&P Kensho Final Frontiers ETF
ROKT
|
+$2.3M |
| 4 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$1.74M |
| 5 |
NEOS Nasdaq 100 High Income ETF
QQQI
|
+$1.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$1.73M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.47M |
| 3 |
Amplify International Enhanced Dividend Income ETF
IDVO
|
+$1.04M |
| 4 |
NEOS S&P 500 High Income ETF
SPYI
|
+$331K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$95.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 0.57% |
| 2 | Utilities | 0.32% |
| 3 | Healthcare | 0.3% |
| 4 | Industrials | 0.26% |
| 5 | Technology | 0.21% |
Similar funds
CCM
WA
IWM
BRWM
HIM
IPAM
GC
PCR
URS Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, URS Advisory held 61 positions worth $180M, up 31% from $137M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
URS Advisory deployed $22.6M of net new capital in Q2 2026, opening 10 new positions and adding to 35 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 28,717 shares worth $4.54M.
By sector, the portfolio is most concentrated in Financials at 0.57% of assets, down from 0.66% a quarter earlier, followed by Utilities and Healthcare.
On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $1.73M trimmed.
- URS Advisory's largest Q2 2026 buy was State Street SPDR S&P Biotech ETF: 28,717 shares worth $4.54M.
- URS Advisory added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $2.54M increase.
- URS Advisory's biggest Q2 2026 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.73M.
- URS Advisory's ten largest holdings make up 68% of its $180M portfolio in Q2 2026.
- URS Advisory opened 10 new positions and closed 0 in Q2 2026.
- URS Advisory's portfolio value rose 31% quarter-over-quarter to $180M.
Based on URS Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.